Customize
Quick Links

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 1.5 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from AstraZeneca.

About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2017
Physicians’ Education Resource ®, LLC.
All rights reserved.

MBCC: Medical Crossfire®: How Do We Leverage PARP Inhibition Strategies in the Contemporary Treatment of Breast Cancer?

MBCC: Medical Crossfire®: How Do We Leverage PARP Inhibition Strategies in the Contemporary Treatment of Breast Cancer?


Friday, March 9, 2018
Breakfast and Registration: 6:30AM – 7:00AM

Fontainebleau Miami Beach
Meeting Room: Fontaine

4441 Collins Avenue
Miami Beach, FL 33140

Overview

Pre-clinical and clinical trial findings pertaining to therapeutic advancements with PARP inhibition in the medical management of patients with breast cancer represent one of the hottest topics in the field. As the evidence base concerning the use of PARP inhibitors continues to grow, there is a great need for clinicians to understand the mechanistic rationale for using PARP inhibitors, as well as factors that may influence the effectiveness of these treatment modalities for patients with breast cancer. Clinicians also need to be cognizant of recent clinical trial evidence that may help to optimize the potential application of PARP inhibitor strategies, including methods to identify and mitigate the impact of treatment-related toxicities. New roles for these therapies are also the focus of numerous ongoing clinical trials.

The dynamic and interactive format of this Medical Crossfire® will focus participants on key aspects regarding the influence of PARP inhibitors on the evolving treatment landscape for patients with breast cancer, and will feature leading clinical experts in the field. This Medical Crossfire® activity will include didactic presentation, interactive case-based discussion among expert panelists, and opportunities for participants to engage faculty with their questions and methods to practically apply learnings from the meeting to their most difficult breast cancer cases.
 

Acknowledgment of Commercial Support

This activity is supported by an educational grant from AstraZeneca.

Target Audience

This educational activity is directed toward medical oncologists who treat patients with breast cancer. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of breast cancer will be invited to participate.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Explain the mechanistic rationale for the use of PARP inhibition in the treatment of cancer and strategies to optimize patient selection for this therapy
  • Analyze historical evidence pertaining to the use of PARP inhibition in ovarian and breast cancers
  • Examine evolving efficacy and safety data concerning the application of PARP inhibitors in the treatment of ovarian and breast cancers, including how this information may inform personalized treatment and mitigation of treatment-related toxicities
  • Summarize key ongoing studies that address expansion of PARP inhibitor use in different settings for patients with breast cancer

Program Chair

Mark E. Robson, MD
Attending Physician
Clinical Genetics and Breast Medicine Services
Clinic Director, Clinical Genetics Service
Memorial Sloan Kettering Cancer Center
New York, NY







Become a Member

Forgot Password?
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
     12
3456789
10111213141516
17181920212223
24252627282930
31
Filter By